* Gamida Cell Ltd GMDA.OQ GMDA.O is expected to show no
change
in quarterly revenue when it reports results on November 14.
*
* Refinitiv's mean analyst estimate for Gamida Cell Ltd is
for a
loss of 31 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Gamida Cell
Ltd
is $15, above its last closing price of $1.86.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.29 -0.29 -0.31 Missed -6.2
Mar. 31 2022 -0.34 -0.34 -0.34 Met 0
Dec. 31 2021 -0.40 -0.40 -0.52 Missed -28.4
Sep. 30 2021 -0.49 -0.48 -0.33 Beat 31.3
Jun. -0.39 -0.40 -0.36 Beat 10.4
30 2021
Mar. 31 2021 -0.40 -0.40 -0.31 Beat 22.2
Dec. 31 2020 -0.34 -0.34 -0.68 Missed -98.1
Sep. 30 2020 -0.31 -0.31 -0.30 Beat 4.3
This summary was machine generated November 11 at 17:22 GMT.
All figures in US dollars unless otherwise stated